Molecular Imaging: Page 313

Neoprobe to change name to Navidea

By AuntMinnie.com staff writers

Radiopharmaceutical developer Neoprobe plans to change its name to Navidea Biopharmaceuticals and to begin trading under a new ticker symbol on the NYSE Amex exchange on January 5, 2012.

December 7, 2011

FDA delays PET drug deadline for 6 months

By Wayne Forrest

Developers of PET radiopharmaceuticals got a reprieve this week: The U.S. Food and Drug Administration announced that it will give them six more months to comply with an upcoming rule change for manufacturing PET drugs that originally was scheduled to go into effect next week.

December 6, 2011

Prana gets OK for Alzheimer's trial

By AuntMinnie.com staff writers

Australian drug developer Prana Biotechnology has received approval from the Australian Austin Health Human Research Ethics Committee to begin a phase II imaging trial to evaluate its PBT2 drug for treating Alzheimer's disease.

December 5, 2011

PiB complements FDG-PET for Alzheimer's

By AuntMinnie.com staff writers

Researchers from the University of California, San Francisco have found that the amyloid ligand Pittsburgh Compound B (PiB) with PET can offer more sensitivity than FDG-PET in discriminating between Alzheimer's disease and frontotemporal lobar degeneration, according to a study in the November 29 issue of Neurology.

December 1, 2011

PET/MRI surpasses PET/CT for some abdominal lesions

By Wayne Forrest

CHICAGO - PET/MRI can outperform PET/CT for lesion conspicuity and characterization in the abdomen, particularly in the liver, according to a study presented by Swiss researchers at the RSNA 2011 meeting.

November 30, 2011

FDG-PET is cost-effective 1st imaging option for dementia

By Wayne Forrest

CHICAGO - FDG-PET is more cost-effective in an initial workup of dementia patients, while amyloid PET imaging is more cost-effective as the secondary imaging option in a tertiary care setting, according to a study presented on Monday at the RSNA 2011 conference.

November 28, 2011

Siemens beefs up CT line, launches ultrasound system

By Wayne Forrest, Brian Casey

CHICAGO - A pair of new CT scanners is pacing the RSNA 2011 product introductions from Siemens Healthcare. The company is also promoting Biograph PET/CT and its new Acuson S1000 ultrasound system, and is demonstrating new product launches in healthcare informatics, digital radiography, and interventional radiology.

November 28, 2011

Medspira adds Breath Hold to Philips BrightView XCT

By AuntMinnie.com staff writers

Respiratory motion monitoring technology developer Medspira has collaborated with Philips Healthcare to offer its Breath Hold interactive breath control monitoring system as an option with Philips' BrightView XCT SPECT/CT systems.

November 28, 2011

Siemens survey explores attitudes about imaging

By AuntMinnie.com staff writers

A new survey of popular attitudes about medical imaging, released at the RSNA 2011 meeting in Chicago, has found that consumer familiarity with specific imaging applications breeds consumer confidence and a willingness to consent to its prescribed use.

November 28, 2011

PET/CT prevents dissections for head and neck cancer patients

By Cynthia E. Keen

CHICAGO - Using F-18 FDG-PET/CT scans to evaluate the response of patients who received chemoradiotherapy for head and neck cancer can prevent unnecessary dissections for some, researchers from the U.K. and the U.S. said at an RSNA 2011 scientific session.

November 28, 2011

Mammography, CT, PET/MRI pace Philips RSNA product debuts

By Cynthia E. Keen, Brian Casey

CHICAGO - Philips Healthcare is highlighting its renewed push in mammography in its RSNA booth, as well as new product introductions in CT and the ongoing development of its PET/MRI program, which got a boost with a key regulatory clearance before the show.

November 28, 2011

Study shows advanced imaging growth coming to an end

By Kate Madden Yee

CHICAGO - The rapid rise in the early 2000s of utilization of advanced imaging modalities such as CT, MRI, and nuclear medicine has come to an end, according to researchers at Thomas Jefferson University in Philadelphia.

November 28, 2011

Previous Page

Page 313 of 612

Next Page